It has long been known that cholesterol and lipid metabolism play a critical role in the development of AD, as seen with the APOE4 isoform of APOE, which increases plasma low-density lipoprotein levels (thereby also increasing risk of atherosclerosis), while also increasing the risk for AD (11). Here, APOE is linked to Alzheimer disease.